Back
Plains All American Pipeline LP Vs. Sarepta Therapeutics, Inc. Industry Stock Comparison
Buy
55
PAA
Plains All American Pipeline LP
Last Price:
$17.87
Seasonality Move:
5.48%
Sell
43
SRPT
Sarepta Therapeutics, Inc.
Last Price:
$21.48
Seasonality Move:
6.08%
Buy
55
Plains All American Pipeline LP (PAA)
is a Buy
Is Plains All American Pipeline LP a Buy, Sell or Hold?
-
The current Plains All American Pipeline LP [PAA] share price is $17.72. The Score for PAA is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
PAA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Sarepta Therapeutics, Inc. (SRPT)
is a Sell
Is Sarepta Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Sarepta Therapeutics, Inc. [SRPT] share price is $21.82. The Score for SRPT is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PAA Stock Price Chart
What is Plains All American Pipeline LP's stock price today?
-
The Plains All American Pipeline LP share price today is $17.72Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PAA is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics, Inc.'s stock price today?
-
The Sarepta Therapeutics, Inc. share price today is $21.82Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
PAA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.16 | Buy |
| Relative Strength Index (14 RSI): | 57.21 | Buy |
| Chaikin Money Flow: | 155015 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.37 - 17.77) | Buy |
| Bollinger Bands (100): | (16.61 - 17.71) | Buy |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.06 | Buy |
| Relative Strength Index (14 RSI): | 54.13 | Buy |
| Chaikin Money Flow: | 1426024 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.03 - 22.43) | Buy |
| Bollinger Bands (100): | (17.92 - 22.36) | Buy |
PAA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.69 | Buy |
| 20-day SMA: | 17.64 | Buy |
| 50-day SMA: | 17.11 | Buy |
| 200-day SMA: | 17.6 | Buy |
| 8-day EMA: | 17.69 | Buy |
| 20-day EMA: | 17.57 | Buy |
| 50-day EMA: | 17.32 | Buy |
| 200-day EMA: | 17.5 | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.5 | Buy |
| 20-day SMA: | 21.62 | Buy |
| 50-day SMA: | 20.75 | Buy |
| 200-day SMA: | 30.1 | Sell |
| 8-day EMA: | 18.84 | Buy |
| 20-day EMA: | 11.91 | Buy |
| 50-day EMA: | 5.9 | Buy |
| 200-day EMA: | 1.65 | Buy |
Plains All American Pipeline LP Earnings Growth & PAA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics, Inc. Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.78 per share, and a decrease next year of $0.00 per share.
Plains All American Pipeline LP Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||